Related Experiment Video
Updated: Jul 16, 2025

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
Published on: June 2, 2020
Extracellular Vesicles and Endocannabinoid Signaling in Patients with COVID-19
Florian Brandes1, Annekathrin M Keiler2, Benedikt Kirchner3
1Department of Anesthesiology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Extracellular vesicles (EVs) transport endocannabinoids in COVID-19 patients, with levels correlating to disease severity. These EVs also carry microRNAs that regulate endocannabinoid signaling pathways in immune cells.
Area of Science:
- Immunology
- Molecular Biology
- Virology
Background:
- Endocannabinoids possess immunomodulatory properties, but their role and regulation in COVID-19 remain unclear.
- Lipophilic endocannabinoids require transport mechanisms across biological barriers, with extracellular vesicles (EVs) being potential carriers.
- Understanding endocannabinoid transport via EVs is crucial for comprehending their function in COVID-19 pathogenesis.
Purpose of the Study:
- To investigate the presence and concentration of endocannabinoids within EVs in COVID-19 patients.
- To explore the relationship between EV-associated endocannabinoids and disease severity.
- To elucidate the role of EV-derived microRNAs (miRNAs) in regulating endocannabinoid signaling pathways in immune cells during COVID-19.
Main Methods:
- Quantification of endocannabinoids (anandamide, 2-AG, SEA, PEA, OEA) in EVs and plasma from COVID-19 patients.
- RNA sequencing to identify EV-miRNAs and blood cell mRNA transcripts for signaling network construction.
- Analysis of correlations between EV-endocannabinoid levels, disease severity, and miRNA expression.
Main Results:
- Endocannabinoid concentrations, except anandamide, were significantly higher in EVs compared to plasma and increased with COVID-19 severity.
- Specific EV-miRNAs (miR-146a-5p, miR-199a-5p, miR-370-5p, miR-30c-5p, miR-26a-5p) were associated with the regulation of endocannabinoid-related genes (CNR2, MGLL, CNR1, FAAH).
- Endocannabinoid signaling influenced immunologically active molecules in immune cells, including VEGFA, GNAI2, IGF1, BDNF, and CREB1.
Conclusions:
- EVs serve as carriers for immunologically functional endocannabinoids and regulatory miRNAs in COVID-19.
- This EV-mediated communication mechanism fine-tunes endocannabinoid signaling and metabolism in recipient immune cells.
- The findings offer insights into a novel pathway for intercellular communication and immune modulation in COVID-19.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Intralumenal Vesicles and Multivesicular Bodies
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Types of Signaling Molecules

